학술논문

Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure
Document Type
article
Source
Environmental Health Perspectives. 117(11)
Subject
Epidemiology
Health Services and Systems
Biomedical and Clinical Sciences
Health Sciences
Cancer
Lung Cancer
Lung
Foodborne Illness
Clinical Research
Aetiology
2.2 Factors relating to the physical environment
Respiratory
Adult
Aged
Arsenic
Carcinoma
Squamous Cell
Case-Control Studies
Environmental Exposure
Female
Humans
Logistic Models
Lung Diseases
Lung Neoplasms
Male
Middle Aged
Nails
New Hampshire
Retrospective Studies
Risk Factors
Selenium
Small Cell Lung Carcinoma
Spectrophotometry
Atomic
Vermont
Water Pollutants
Chemical
arsenic
bronchitis
chronic obstructive pulmonary disease
lung cancer
lung diseases
pulmonary fibrosis
small-cell carcinoma
smoking
Environmental Sciences
Medical and Health Sciences
Toxicology
Biomedical and clinical sciences
Environmental sciences
Health sciences
Language
Abstract
BackgroundLittle is known about the carcinogenic potential of arsenic in areas with low to moderate concentrations of arsenic (< 100 microg/L) in drinking water.ObjectivesWe examined associations between arsenic and lung cancer.MethodsA population-based case-control study of primary incident lung cancer was conducted in 10 counties in two U.S. states, New Hampshire and Vermont. The study included 223 lung cancer cases and 238 controls, each of whom provided toenail clippings for arsenic exposure measurement by inductively coupled-plasma mass spectrometry. We estimated odds ratios (ORs) of the association between arsenic exposure and lung cancer using unconditional logistic regression with adjustment for potential confounders (age, sex, race/ethnicity, smoking pack-years, education, body mass index, fish servings per week, and toenail selenium level).ResultsArsenic exposure was associated with small-cell and squamous-cell carcinoma of the lung [OR = 2.75; 95% confidence interval (CI), 1.00-7.57] for toenail arsenic concentration > or = 0.114 microg/g, versus < 0.05 microg/g. A history of lung disease (bronchitis, chronic obstructive pulmonary disease, or fibrosis) was positively associated with lung cancer (OR = 2.86; 95% CI, 1.39-5.91). We also observed an elevated risk of lung cancer among participants with a history of lung disease and toenail arsenic > or = 0.05 microg/g (OR = 4.78; 95% CI, 1.87-12.2) than among individuals with low toenail arsenic and no history of lung disease.ConclusionAlthough this study supports the possibility of an increased risk of specific lung cancer histologic types at lower levels of arsenic exposure, we recommend large-scale population-based studies.